PDS Biotechnology Corp Operating Lease Right-of-Use Assets
PDS Biotechnology Corp (PDSB) had Operating Lease Right-of-Use Assets of $0 as of 2023-12-31, per its 10-K filed 2024-03-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-03-27
- 2023-12-31: Operating Lease, Right-of-Use Asset $0.00.
- 2023-09-30: Operating Lease, Right-of-Use Asset $0.00.
- 2023-06-30: Operating Lease, Right-of-Use Asset $39.49K.
- 2023-03-31: Operating Lease, Right-of-Use Asset $97.04K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $39.49K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $97.04K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $152.65K 10-K · filed 2024-03-28 |
| 2022-09-30 | $206.35K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $258.19K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $308.33K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $357.61K 10-K · filed 2023-03-28 |
| 2021-09-30 | $406.17K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $454.03K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $501.19K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $547.71K 10-K · filed 2022-03-31 |
| 2020-09-30 | $593.58K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $638.83K 10-Q · filed 2020-08-13 |
| 2020-05-01 | $700.00K 10-K · filed 2025-03-27 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-18 |
| 2019-08-31 | $1.20M 10-K · filed 2021-03-18 |
| 2019-06-30 | $1.23M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.35M 10-Q · filed 2019-05-14 |
| 2019-03-15 | $1.40M 10-K · filed 2021-03-18 |
| 2018-12-31 | $0.00 10-Q · filed 2019-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |